The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):e1-8. doi: 10.1097/QAI.0b013e3181ff0bdc.
To assess sustainability of programmatic outcomes in a community-based antiretroviral therapy (ART) service in South Africa during 7 years of scale-up.
Prospective cohort of treatment-naive patients aged ≥ 15 years enrolled between 2002 and 2008. Data were analyzed by calendar period of ART initiation using time-to-event analysis and logistic regression.
ART was initiated by 3162 patients (67% women; median age, 34 years) who were followed-up for a median of 2.4 years (interquartile range, 1.2-3.8). After 6 years, the cumulative probability of death and loss to follow-up (LTFU) was 37.4%. The probabilities of transfer-out to another ART service and of virological failure were 21.6% and 23.1%, respectively. Low mortality risk and excellent virological and immunological responses during the first year of ART were not associated with calendar period of ART initiation. In contrast, risk of LTFU and virological failure both increased between successive calendar periods in unadjusted and adjusted analyses. The number of patients per member of clinic staff increased markedly over time.
Successful early outcomes (low mortality and good immunological and virological responses) were sustained between sequential calendar periods during 7 years of scale-up. In contrast, the increasing cumulative probabilities of LTFU or virological failure may reflect decreasing capacity to adequately support patients during long-term therapy as clinic caseload escalated.
在南非一个社区为基础的抗逆转录病毒治疗(ART)服务中,评估方案成果在 7 年扩展期间的可持续性。
前瞻性队列研究了 2002 年至 2008 年间入组的治疗初治、年龄≥15 岁的患者。通过 ART 启动的日历时间段进行数据分析,采用时间事件分析和逻辑回归。
3162 名患者(67%为女性;中位年龄 34 岁)开始接受 ART,中位随访时间为 2.4 年(四分位间距 1.2-3.8)。6 年后,死亡和失访(LTFU)的累积概率为 37.4%。转出到另一个 ART 服务和病毒学失败的概率分别为 21.6%和 23.1%。ART 治疗第一年低死亡率和良好的病毒学及免疫学反应与 ART 启动的日历时间段无关。相反,未调整和调整后的分析均显示,LTFU 和病毒学失败的风险在连续的日历时间段中均增加。每位诊所工作人员管理的患者人数随时间显著增加。
在 7 年的扩展期间,连续的日历时间段中成功实现了早期成果(低死亡率和良好的免疫及病毒学反应)的可持续性。相比之下,随着诊所工作量的增加,LTFU 或病毒学失败的累积概率增加可能反映出在长期治疗期间,为患者提供充分支持的能力下降。